Canada Pension Plan Investment Board Nektar Therapeutics Transaction History

Canada Pension Plan Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $530 - $902	-49 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $52,897 - $65,320	-3,202 Reduced 98.49%	49 $1,000
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $271,368 - $417,213	-16,387 Reduced 83.45%	3,251 $65,000
Q4 2020 Feb 17, 2021	SELL	$15.77 - $19.03 $3,784 - $4,567	-240 Reduced 1.21%	19,638 $334,000
Q3 2020 Nov 12, 2020	SELL	$16.59 - $24.79 $196,276 - $293,290	-11,831 Reduced 37.31%	19,878 $330,000
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $493,003 - $685,409	29,241 Added 1184.81%	31,709 $734,000
Q1 2020 May 13, 2020	BUY	$14.47 - $27.96 $35,711 - $69,005	2,468 New	2,468 $44,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $146M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.